topotecan has been researched along with Encephalitis, JC Polyomavirus in 10 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 7 (70.00) | 18.2507 |
2000's | 1 (10.00) | 29.6817 |
2010's | 2 (20.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kameoka, M; Nakamichi, K; Nukuzuma, C; Nukuzuma, S; Sugiura, S; Takegami, T; Tasaki, T | 2 |
Apuzzo, L; Chang, L; Concha, M; Dupont, B; Ernst, T; Fish, D; Goodkin, K; McGuire, D; Pailloux, G; Poncelet, H; Post, MJ; Royal, W; Singer, E | 1 |
Smart, T | 2 |
Learned, J | 1 |
Bowers, M | 1 |
1 trial(s) available for topotecan and Encephalitis, JC Polyomavirus
Article | Year |
---|---|
Topotecan in the treatment of acquired immunodeficiency syndrome-related progressive multifocal leukoencephalopathy.
Topics: Acquired Immunodeficiency Syndrome; Adult; Antiretroviral Therapy, Highly Active; Brain; CD4 Lymphocyte Count; Cohort Studies; Drug Administration Schedule; Enzyme Inhibitors; Female; Hematologic Diseases; HIV-1; Humans; Karnofsky Performance Status; Leukoencephalopathy, Progressive Multifocal; Magnetic Resonance Imaging; Male; Middle Aged; RNA, Viral; Topoisomerase I Inhibitors; Topotecan; Treatment Outcome; Viral Load | 2003 |
9 other study(ies) available for topotecan and Encephalitis, JC Polyomavirus
Article | Year |
---|---|
CPT11 prevents virus replication in JCI cells persistently infected with JC polyomavirus.
Topics: Antiviral Agents; Camptothecin; Cell Line; Cell Proliferation; DNA Replication; DNA, Viral; Dose-Response Relationship, Drug; Humans; Inhibitory Concentration 50; JC Virus; Leukoencephalopathy, Progressive Multifocal; Naphthoquinones; Real-Time Polymerase Chain Reaction; Topoisomerase I Inhibitors; Topotecan; Viral Proteins; Virus Replication | 2017 |
Suppressive effect of topoisomerase inhibitors on JC polyomavirus propagation in human neuroblastoma cells.
Topics: Antiviral Agents; Cell Line; Cell Proliferation; DNA Replication; DNA, Viral; Humans; JC Virus; Leukoencephalopathy, Progressive Multifocal; Naphthoquinones; Neuroblastoma; Topoisomerase I Inhibitors; Topoisomerase Inhibitors; Topotecan; Virus Replication | 2016 |
PML and a tale of two drug companies.
Topics: AIDS-Related Opportunistic Infections; Albendazole; Blood-Brain Barrier; Camptothecin; Drug Industry; Humans; Irinotecan; JC Virus; Leukoencephalopathy, Progressive Multifocal; Microsporidiosis; Polymerase Chain Reaction; Topotecan | 1995 |
Topotecan now available for HIV, PML research.
Topics: Antineoplastic Agents; Camptothecin; HIV Infections; Humans; Leukoencephalopathy, Progressive Multifocal; Topotecan | 1995 |
Topotecan research moves forward at last.
Topics: Antineoplastic Agents; Antiviral Agents; Camptothecin; Clinical Trials as Topic; HIV Long Terminal Repeat; HIV-1; Humans; Leukoencephalopathy, Progressive Multifocal; Lymphoma; Mutation; Sarcoma, Kaposi; Topoisomerase I Inhibitors; Topotecan; Virus Replication | 1995 |
Making inroads on PML.
Topics: Acquired Immunodeficiency Syndrome; Camptothecin; HIV Protease Inhibitors; Humans; Irinotecan; Leukoencephalopathy, Progressive Multifocal; Topotecan | 1996 |
Topotecan and PML: the limits of pharmaceutical industry research.
Topics: AIDS-Related Opportunistic Infections; Antineoplastic Agents; Camptothecin; Clinical Trials, Phase II as Topic; Consumer Advocacy; Drug Approval; Drug Evaluation, Preclinical; Drug Industry; Health Services Accessibility; HIV Infections; Humans; JC Virus; Leukoencephalopathy, Progressive Multifocal; Ovarian Neoplasms; Topotecan | 1996 |
PML update.
Topics: Acquired Immunodeficiency Syndrome; Camptothecin; Clinical Trials, Phase II as Topic; Enzyme Inhibitors; Humans; Leukoencephalopathy, Progressive Multifocal; Topotecan | 1997 |
Progressive multifocal leukoencephalopathy.
Topics: AIDS-Related Opportunistic Infections; Antineoplastic Agents; Antiviral Agents; Brain; Clinical Trials as Topic; Cytosine; Humans; Leukoencephalopathy, Progressive Multifocal; Organophosphorus Compounds; Topotecan | 1997 |